SCIENTIFIC REPORT

Pseudo-endophthalmitis after intravitreal injection of triamcinolone

F K P Sutter and M C Gillies

Save Sight Institute, Department of Clinical Ophthalmology and Eye Health, The University of Sydney, Sydney, Australia

Correspondence to:
Correspondence to:
Dr F Sutter, Universitäts Spital Zürich, Augenklinik, Frauenklinikstrasse 24, CH-8091, Zürich, Switzerland;
sutter-adler{at}gmx.ch

Aims: To describe an unusual endophthalmitis-like reaction after an intravitreal injection of triamcinolone acetonide in four patients.

Methods: Retrospective case series.

Results: Four patients are reported with an endophthalmitis-like reaction following an intravitreal injection of triamcinolone acetonide. There was a dense vitreous haze with severe reduction of fundus view in all cases. One case was treated as an infectious endophthalmitis but the vitreous tap showed no evidence of an endophthalmitis and no bacterial or fungal growth in culture. In all four cases, the vitreous haze cleared without specific treatment. The anterior chamber remained quiet in all cases but one, which was examined 30 minutes after the injection, and there was no periorbital inflammation or pain.

Conclusion: Pseudo-endophthalmitis after an intravitreal injection of triamcinolone acetonide seems to be a distinct clinical entity that may resolve without specific treatment.

Keywords: pseudo-endophthalmitis; triamcinolone; corticosteroids

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

BJO at a glance

Creig Hoyt
Br. J. Ophthalmol. 2003 87: 931. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Iwama, D, Otani, A, Sasahara, M, Yodoi, Y, Gotoh, N, Tamura, H, Tsujikawa, A, Yoshimura, N (2008). Photodynamic therapy combined with low-dose intravitreal triamcinolone acetonide for age-related macular degeneration refractory to photodynamic therapy alone. Br. J. Ophthalmol. 92: 1352-1356 [Abstract] [Full Text]  
• Jonisch, J, Lai, J C, Deramo, V A, Flug, A J, Fastenberg, D M (2008). Increased incidence of sterile endophthalmitis following intravitreal preserved triamcinolone acetonide. Br. J. Ophthalmol. 92: 1051-1054 [Abstract] [Full Text]  
• Deng, S. X., Penland, S., Gupta, S., Fiscella, R., Edward, D. P., Tessler, H. H., Goldstein, D. A. (2006). Methotrexate reduces the complications of endophthalmitis resulting from intravitreal injection compared with dexamethasone in a rabbit model.. IOVS 47: 1516-1521 [Abstract] [Full Text]  
• Zarbin, M. (2006). Should corticosteroids be considered as part of the standard care with photodynamic therapy?. Arch Ophthalmol 124: 563-571 [Full Text]  
• Narayanan, R., Mungcal, J. K., Kenney, M. C., Seigel, G. M., Kuppermann, B. D. (2006). Toxicity of Triamcinolone Acetonide on Retinal Neurosensory and Pigment Epithelial Cells. IOVS 47: 722-728 [Abstract] [Full Text]  
• Jonas, J. B., Martus, P., Degenring, R. F., Kreissig, I., Akkoyun, I. (2005). Predictive Factors for Visual Acuity After Intravitreal Triamcinolone Treatment for Diabetic Macular Edema. Arch Ophthalmol 123: 1338-1343 [Abstract] [Full Text]  
• Garcia-Arumi, J, Boixadera, A, Giralt, J, Martinez-Castillo, V, Gomez-Ulla, F, Corcostegui, B, Garcia-Arumi, E (2005). Comparison of different techniques for purification of triamcinolone acetonide suspension for intravitreal use. Br. J. Ophthalmol. 89: 1112-1114 [Abstract] [Full Text]  
• Westfall, A. C., Osborn, A., Kuhl, D., Benz, M. S., Mieler, W. F., Holz, E. R. (2005). Acute Endophthalmitis Incidence: Intravitreal Triamcinolone. Arch Ophthalmol 123: 1075-1077 [Abstract] [Full Text]  
• Spandau, U H M, Derse, M, Schmitz-Valckenberg, P, Papoulis, C, Jonas, J B (2005). Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema. Br. J. Ophthalmol. 89: 999-1003 [Abstract] [Full Text]  
• Flynn, H. W. Jr, Scott, I. U. (2005). Intravitreal Triamcinolone Acetonide for Macular Edema Associated With Diabetic Retinopathy and Venous Occlusive Disease: It's Time for Clinical Trials. Arch Ophthalmol 123: 258-259 [Full Text]  
• Jonas, J B, Kreissig, I, Degenring, R F (2004). Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration. Br. J. Ophthalmol. 88: 1557-1562 [Abstract] [Full Text]  
• Chen, S. D. M., Lockhead, J., Patel, C. K. (2004). Diffuse Intraocular Dispersion of Triamcinolone Particles as a Cause of Sterile Endophthalmitis. Arch Ophthalmol 122: 1733-1733 [Full Text]  
• Ciardella, A P, Klancnik, J, Schiff, W, Barile, G, Langton, K, Chang, S (2004). Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study. Br. J. Ophthalmol. 88: 1131-1136 [Abstract] [Full Text]  
• Jonas, J B, Bleyl, U (2004). Morphallaxia-like ocular histology after intravitreal triamcinolone acetonide. Br. J. Ophthalmol. 88: 839-840 [Full Text]  
• Chen, S D M, Lochhead, J, McDonald, B, Patel, C K (2004). Pseudohypopyon after intravitreal triamcinolone injection for the treatment of pseudophakic cystoid macular oedema. Br. J. Ophthalmol. 88: 843-844 [Full Text]  
• Gillies, M. C., Simpson, J. M., Billson, F. A., Luo, W., Penfold, P., Chua, W., Mitchell, P., Zhu, M., Hunyor, A. B. L. (2004). Safety of an Intravitreal Injection of Triamcinolone: Results From a Randomized Clinical Trial. Arch Ophthalmol 122: 336-340 [Abstract] [Full Text]  
• Jonas, J. B., Kreissig, I., Degenring, R. F. (2003). Endophthalmitis After Intravitreal Injection of Triamcinolone Acetonide. Arch Ophthalmol 121: 1663-1664 [Full Text]  

eLetters:

Read all eLetters

Acute reaction to the preservative of Kenacort

Maria C. Hernaez-Ortega, et al.

BJO Online, 24 Sep 2003 [Full text]